Lexaria Bioscience Corp (OTCMKTS:LXRP) reported on January 5, 2018, it submitted a shareholder information and registration statement circular on Form S-4 with the U.S. SEC following...
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) considers it can fund capital requirements and operations well into 2019. As of the close of September 30, 2017, the firm posted...
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) reported that to complement the concentration in near-rare and rare neuropsychiatric problems, Liza A. Squires, MD has been engaged to the newly...
As Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) head into 2018, the management look forward to delivering on several significant clinical and corporate milestones that are vital to their...
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) reported that it will concentrate its measures on rare and near-rare psychiatric and neurological disorders with immense unmet medical needs. This year,...
Nemus Bioscience Inc (OTCMKTS:NMUS) has entered into deals with Emerald Health Sciences Inc. including the “Bridge Loan” and a Security Deal. The Bridge Loan offers for...
For Q3 2017, Medicine Man Technologies Inc (OTCMKTS:MDCL) reported revenue of $928,624 as compared to $236,593 in the comparable period in 2016, led primarily by a...
INSYS Therapeutics Inc (NASDAQ:INSY) reported that the U.S. FDA has allowed Fast Track designation to the firm’s cannabidiol oral solution for the cure of Prader-Willi syndrome....
In the last trading session, the stock price of Medicine Man Technologies Inc (OTCMKTS:MDCL) declined more than 27% to close the day at $2.29. The decline...
Pivot Pharmaceuticals Inc (OTCMKTS:PVOTF) and its medical cannabis products segment, Pivot Green Stream Health Solutions Inc. reported that they have signed a letter of intent to...
